Powder: -20°C for 3 years | In solvent: -80°C for 1 year
URAT1 inhibitor 3 是具有口服活性的URAT1的选择性抑制剂(IC 50 = 0.8 nM)。URAT1 inhibitor 3 显示出降低尿酸的功效,可用于研究痛风和高尿酸血症。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 10,600 | 10-14周 | ||
50 mg | ¥ 13,800 | 10-14周 | ||
100 mg | ¥ 17,500 | 10-14周 |
产品描述 | URAT1 inhibitor 3 is a potent, orally active, selective inhibitor of URAT1(IC 50 = 0.8 nM). URAT1 inhibitor 3 shows urate-lowering efficacy that can be used in gout and hyperuricemi research [1]. |
体外活性 | URAT1 inhibitor 3 (0-400 μM; 24 and 72 h; HepG2 and HK2 cells) has low toxicity and inhibits cell viability at high concentrations [1]. URAT1 inhibitor 3 (0.01-100 μM) has lower inhibition on urate excretion transporters with IC 50 values of 10.16 μM and 4.04 μM of OAT1 and ABCG2, respectively [1]. Cell Viability Assay [1] Cell Line: HepG2 and HK2 cells Concentration: 0, 100, 200, 300, and 400 μM Incubation Time: 24 and 72 hours Result: Had little cytotoxicity at 24 h and inhibition rate of 34.75% and 35.9% of HepG2 and HK2 cells, respectively. |
体内活性 | URAT1 inhibitor 3 (1-4 mg/kg; i.g.; once) has urate lowering efficacy in a mouse model of hyperuricemia [1]. URAT1 inhibitor 3 (50 mg/kg; i.g.; daily, for 14 d) has no hepatic and renal toxicities in mice [1]. URAT1 inhibitor 3 (50 mg/kg; i.g.; once) induces GSH depletion in Kunming mice with hyperuricemia model [1]. Animal Model: Male Kunming (KM) mice with hyperuricemia model [1] Dosage: 1, 2, and 4 mg/kg Administration: Oral gavage; once Result: Decreased the serum urate levels in a dose-dependent manner. Animal Model: Male Kunming mice [1] Dosage: 50 mg/kg Administration: Oral gavage; daily, for 14 days Result: Did not cause renal toxicity. Animal Model: Male Kunming mice with hyperuricemia model [1] Dosage: 50 mg/kg Administration: Oral gavage; once Result: Decreased the serum GSH levels from 42.23 μM to 20.39 μM. |
分子量 | 307.13 |
分子式 | C14H8Cl2N2O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
URAT1 inhibitor 3 Inhibitor inhibitor inhibit